Global insights driving the market strategies of tomorrow.

Hims & Hers Health (HIMS.US) will launch a generic version of Novo Nordisk's (NVO.US) old weight loss therapy

Market IntelTuesday, Nov 5, 2024 8:40 am ET

1min read

Intellidex learned that Hims & Hers Health (HIMS.US) CEO Andrew Dudum said the company is preparing to launch a generic version of Novo Nordisk (NVO.US)’s older GLP-1 weight loss therapy liraglutide in 2025.

liraglutide is sold under the brand names Victoza and Saxenda for diabetes and obesity.

liraglutide brought the Danish drugmaker 8.3 billion Danish kroner ($1.2 billion) in revenue in the first half of 2024, down about 22% year-on-year, as it lost market exclusivity this year as part of the company’s earlier GLP-1 product portfolio.

Hims & Hers Health co-founder Dudum added: “We have identified our core suppliers for this new product and expect to complete testing and bulk validation, and confirm authenticity certificates, in the coming months.”

He made the comments during the company’s earnings call. Earlier, the California-based healthcare technology company beat Wall Street expectations for its 2024 third-quarter earnings and raised its full-year outlook, driving its stock higher in premarket trading.

Hims & Hers Health launched a combination version of Novo Nordisk’s popular weight loss therapy semaglutide, known as Wegovy, at a steep discount in May this year.

Comments

Add a public comment...

Post

gameon-manhattan

11/05

If you're invested in $HIMS, don't stress over a sudden -5% dip. Many short sellers are stuck at 16$ and will do whatever it takes to get there, but it's already too late for them. They can't stop HIMS; they've lost. The price is headed for $27 whether they like it or not. Remember, 1) Never short the market. 2) Never short a company making profit. 3) Never short a company with 2 million subscribers and growing numbers 💄💋🫦 #HIMSholdings #stockmarket #subscribers #nevershort

cfeltus23

$HIMS took a dip from -7 to +7%, which seems pretty standard.

Antinetdotcom

$HIMS hasn’t been a good investment due to continuous losses and high expenses on customer acquisition, which haven't led to long-term profitability. It's unlikely to improve soon either! It might be the darling right now, but wait until next year.

Excellent-Win-4625

$NVO Trump's victory means no more price cap restrictions. Expect a 10%+ surge tomorrow along with impressive "no crash" earnings.

KookyPossibleTheme

$NVO I expect the biggest drop to happen tomorrow. A $2 decline per day is a clear sign of trouble, so be on your guard. I anticipate a 10% drop tomorrow, potentially bringing the price down to $92.

OutsidePerspective27

$HIMS is seeing a significant boost at a 20% increase.

therealchengarang

$NVO just added some more calls ahead of tomorrow's numbers, hoping for an upside surprise and a significant jump after taking a hit for nearly two months.

bobbybobby911

$NVO Earnings are scheduled for November 06, BMO. A straddle between 08-Nov-24 implies a potential move of ±6.8%, compared to the 6-quarter absolute average of 4.8%. Check out the details here: https://tinyurl.com/2fmda2vl

Senyorty12

$NVO Did they move the earnings announcement to tomorrow? I'm pretty sure it was scheduled for today.

Dynasty__93

$HIMS Just waitin' to scoop up more at the open. Hahahaha, it's like free money!

Value Vet

$HIMS Pre-market, this should be $24. It's clear the establishment dislikes HIMS and its CEO. Just now, I Googled "HIMS hires women" to get Dr. Shepherd's name right for my last post. Not a single article about her hiring showed up. The top five articles were from May and focused on Andrew Dudum's antisemitism. When I entered the same keywords on DuckDuckGo, articles about Dr. Shepherd's hiring were abundant. We're fed up with the Zionist censorship. This isn't a conspiracy... If you believe it is, then it's willful ignorance on your part.

WOSES TODD

I've never expected such a return in my investment, I made $17,580 in a couple of two weeks. I started with a little amount of $5000 from my savings after I lost my job. Thanks to Mrs (Anne-Lynda Murray's) and her platform on Facebook.
She helped me through my investment journey.

No More Comment